CrossrefInfokarte
Myeloablative haploidentical t‐cell replete hematopoietic cell transplantation with post‐transplant cyclophosphamide in high‐risk hematological malignancies: Bending the learning curve in a middle‐income setting
ADVANCES IN CELL AND GENE THERAPY · 2021
DOI: 10.1002/acg2.106 ↗Abstract
Kein Abstract verfügbar.
EUVIMED